本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trevi Therapeutics Inc.

14.95
-0.2600-1.71%
盤後14.950.00000.00%19:30 EDT
成交量:213.85萬
成交額:3,198.59萬
市值:21.23億
市盈率:-42.50
高:15.38
開:15.17
低:14.81
收:15.21
52周最高:20.22
52周最低:8.03
股本:1.42億
流通股本:1.18億
量比:1.13
換手率:1.81%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
淨資產收益率:-19.66%
總資產收益率:-13.82%
市淨率:6.60
市盈率(LYR):-47.11

資料載入中...

2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/23

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/21

重要事件披露

Form 8-K - Current report
2024/10/04

重要事件披露

Form 8-K - Current report
2024/10/01

重要事件披露

Form 8-K - Current report
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/11

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report